标题
Glioblastoma and Other Primary Brain Malignancies in Adults
作者
关键词
-
出版物
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 329, Issue 7, Pages 574
出版商
American Medical Association (AMA)
发表日期
2023-02-22
DOI
10.1001/jama.2023.0023
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
- (2022) Daniel J. Brat et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study
- (2022) Georgios Mantziaris et al. JOURNAL OF NEURO-ONCOLOGY
- Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma
- (2022) Ingo K. Mellinghoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Do Cell Phones Cause Brain Tumors? Another Piece of the Puzzle
- (2022) Douglas L Weed JNCI-Journal of the National Cancer Institute
- Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study
- (2022) Joachim Schüz et al. JNCI-Journal of the National Cancer Institute
- Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study
- (2022) Lauren Reed-Guy et al. NEURO-ONCOLOGY
- Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
- (2022) Antonio Omuro et al. NEURO-ONCOLOGY
- Ependymoma: Evaluation and Management Updates
- (2022) Roberta Rudà et al. Current Oncology Reports
- Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
- (2022) Caroline Houillier et al. JOURNAL OF CLINICAL ONCOLOGY
- Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
- (2022) Andrew B. Lassman et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial
- (2022) Tomoki Todo et al. NATURE MEDICINE
- European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL)
- (2022) Khê Hoang-Xuan et al. NEURO-ONCOLOGY
- Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
- (2022) Jaime Gállego Pérez-Larraya et al. NEW ENGLAND JOURNAL OF MEDICINE
- NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
- (2022) Christina I. Tsien et al. JOURNAL OF CLINICAL ONCOLOGY
- Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
- (2022) Priscilla K. Brastianos et al. JOURNAL OF CLINICAL ONCOLOGY
- Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
- (2022) Julie J Miller et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019
- (2022) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies
- (2021) Andrew W. Swartz et al. ONCOLOGIST
- Evidence-based recommendations on categories for extent of resection in diffuse glioma
- (2021) Philipp Karschnia et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
- (2021) Martin J van den Bent et al. LANCET ONCOLOGY
- A vaccine targeting mutant IDH1 in newly diagnosed glioma
- (2021) Michael Platten et al. NATURE
- Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
- (2021) Ingo K. Mellinghoff et al. CLINICAL CANCER RESEARCH
- Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma
- (2021) Miyabi Saito et al. JOURNAL OF NEURO-ONCOLOGY
- Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results
- (2021) Wenya Linda Bi et al. NEURO-ONCOLOGY
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors
- (2021) Tobias Walbert et al. NEURO-ONCOLOGY
- Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
- (2021) Jasmin Jo et al. NEURO-ONCOLOGY
- A Molecularly Integrated Grade for Meningioma
- (2021) Joseph Driver et al. NEURO-ONCOLOGY
- Primary Central Nervous System Lymphoma
- (2021) Lauren R. Schaff et al. BLOOD
- Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
- (2021) Patrick Y Wen et al. LANCET ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
- (2021) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
- (2021) Eric Jonasch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
- (2021) Angela Lee et al. THROMBOSIS RESEARCH
- Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
- (2020) Annette M. Molinaro et al. JAMA Oncology
- Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
- (2020) Patrick Y Wen et al. NEURO-ONCOLOGY
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Optimal Management of Corticosteroids in Patients with Intracranial Malignancies
- (2020) Karan S. Dixit et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
- (2020) Ingo K. Mellinghoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
- (2020) Erica H. Bell et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes
- (2019) Abdurrahman I. Islim et al. JOURNAL OF NEURO-ONCOLOGY
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
- (2019) Caroline Houillier et al. JOURNAL OF CLINICAL ONCOLOGY
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
- (2019) Philip Jonsson et al. CLINICAL CANCER RESEARCH
- Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma
- (2019) Leon D. Kaulen et al. JOURNAL OF NEURO-ONCOLOGY
- Risk Factors For Childhood And Adult Primary Brain Tumors
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Letter: When Less is More: Dexamethasone Dosing for Brain Tumors
- (2019) Mary Jane Lim-Fat et al. NEUROSURGERY
- Unknown
- (2018) CANCER
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
- (2017) Martin J van den Bent et al. LANCET
- European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
- (2017) Andrea Pace et al. LANCET ONCOLOGY
- Surgical oncology for gliomas: the state of the art
- (2017) Nader Sanai et al. Nature Reviews Clinical Oncology
- EANO guidelines for the diagnosis and treatment of ependymal tumors
- (2017) Roberta Rudà et al. NEURO-ONCOLOGY
- The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades
- (2017) Joe S Mendez et al. NEURO-ONCOLOGY
- Mutant IDH1 and seizures in patients with glioma
- (2017) Hao Chen et al. NEUROLOGY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
- (2017) Christian Grommes et al. Cancer Discovery
- Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
- (2017) Andrés J M Ferreri et al. Lancet Haematology
- The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
- (2016) Kristian W. Pajtler et al. ACTA NEUROPATHOLOGICA
- Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study
- (2016) E. S. Amirian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials
- (2016) Edward K. Avila et al. NEURO-ONCOLOGY
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
- (2016) Jan C. Buckner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent venous thromboembolism in glioblastoma
- (2016) Natasha Catherine Edwin et al. THROMBOSIS RESEARCH
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme
- (2015) Wilson Roa et al. JOURNAL OF CLINICAL ONCOLOGY
- Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States
- (2015) Varun R. Kshettry et al. NEURO-ONCOLOGY
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Quantifying the heritability of glioma using genome-wide complex trait analysis
- (2015) Ben Kinnersley et al. Scientific Reports
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
- (2014) Thomas J. Kaley et al. NEURO-ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
- (2012) Emil Lou et al. JOURNAL OF NEURO-ONCOLOGY
- Atypical and anaplastic meningiomas treated with bevacizumab
- (2012) Lakshmi Nayak et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review
- (2012) M. Z. Braganza et al. NEURO-ONCOLOGY
- Thromboembolic disease in patients with high-grade glioma
- (2012) J. R. Perry NEURO-ONCOLOGY
- Predictors of Survival among Pediatric and Adult Ependymoma Cases: A Study Using Surveillance, Epidemiology, and End Results Data from 1973 to 2007
- (2012) E. Susan Amirian et al. NEUROEPIDEMIOLOGY
- PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
- (2010) J. R. PERRY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Headache attributed to intracranial tumours: a prospective cohort study
- (2009) L Valentinis et al. CEPHALALGIA
- High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
- (2009) Andrés JM Ferreri et al. LANCET
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now